Skip to content
August 10, 2026
  • AI in Drug Development is Not a Data Problem — It’s An Evidence Problem
  • How to Keep Clinicians Satisfied, the Ascension Way
  • Compliance Alone Won’t Fix the Home Health Fraud Problem
  • Many States Cover Doula Care, but Access to a ‘Birthing Bestie’ Is Often Out of Reach

Medical Article

Newsletter
Random News
Headlines
  • AI in Drug Development is Not a Data Problem — It’s An Evidence Problem

    1 hour ago
  • How to Keep Clinicians Satisfied, the Ascension Way

    3 hours ago
  • Compliance Alone Won’t Fix the Home Health Fraud Problem

    3 hours ago
  • Many States Cover Doula Care, but Access to a ‘Birthing Bestie’ Is Often Out of Reach

    6 hours ago
  • Same Knee Surgery, Twice the Price: Hospital Monopolies Push Up Healthcare Costs

    6 hours ago
  • Braveheart Bio’s $382M IPO for Heart Drug Leads a Big Week for Biotech IPOs

    11 hours ago
  • Medicine
1 hour ago

AI in Drug Development is Not a Data Problem — It’s An Evidence Problem

Drug development isn’t limited by the amount of data we collect, but by our ability…

  • Medicine
3 hours ago

How to Keep Clinicians Satisfied, the Ascension Way

Ascension is pushing AI beyond note-taking to tackle the billing, order entry and nursing handoff…

  • Medicine
3 hours ago

Compliance Alone Won’t Fix the Home Health Fraud Problem

[Sponsored] With home health fraud growing more sophisticated through AI, post-pay audits are no longer…

  • Articles
6 hours ago

Many States Cover Doula Care, but Access to a ‘Birthing Bestie’ Is Often Out of Reach

Doula Taja Iglesias and her business partner have built a space in Alexandria, Virginia, that’s…

  • Articles

Sights, Sounds Trigger Trauma for Super Bowl Parade Shooting Survivors

  • Articles

Best practices for conducting a scoping review

  • Other

Emerging Models for Integrating Academic, Community Physician Organizations

  • Medicine

Novo Nordisk Adds Obesity and Diabetes to AI Drug Research Pact With Flagship’s Valo Health

  • Medicine

AI in Drug Development is Not a Data Problem — It’s An Evidence Problem

1 hour ago01 mins

Drug development isn’t limited by the amount of data we collect, but by our ability to preserve the context, meaning and relationships that transform data into evidence. The post AI in Drug Development is Not a Data Problem — It’s An Evidence Problem appeared first on MedCity News.

Read More
  • Medicine

How to Keep Clinicians Satisfied, the Ascension Way

3 hours ago01 mins

Ascension is pushing AI beyond note-taking to tackle the billing, order entry and nursing handoff work still weighing on clinicians after a patient visit ends. The post How to Keep Clinicians Satisfied, the Ascension Way appeared first on MedCity News.

Read More
  • Medicine

Compliance Alone Won’t Fix the Home Health Fraud Problem

3 hours ago01 mins

[Sponsored] With home health fraud growing more sophisticated through AI, post-pay audits are no longer enough. Payers must shift to proactive, tech-driven prevention to catch improper claims before paying them. The post Compliance Alone Won’t Fix the Home Health Fraud Problem appeared first on MedCity News.

Read More
  • Articles

Many States Cover Doula Care, but Access to a ‘Birthing Bestie’ Is Often Out of Reach

6 hours ago013 mins

Doula Taja Iglesias and her business partner have built a space in Alexandria, Virginia, that’s all things pregnancy, birth, and childcare. Comfortable couches in one area invite expectant parents to settle in for birth education classes. In another, a colorful pile of toys await the babies and toddlers. And there’s a free supply of diapers…

Read More
  • Articles

Same Knee Surgery, Twice the Price: Hospital Monopolies Push Up Healthcare Costs

6 hours ago023 mins

More than a million times a year, a U.S. surgeon slices open a knee, strips out worn cartilage, caps the leg bones with metal, and drops in a plastic spacer to allow the new joint to glide. While knee replacement procedures have become standard, however, the prices charged have not. At Catawba Valley Medical Center…

Read More
  • Medicine

Braveheart Bio’s $382M IPO for Heart Drug Leads a Big Week for Biotech IPOs

11 hours ago01 mins

In addition to pricing the biggest biotech IPO of the week, Braveheart Bio’s underwriters exercised their option to purchase more shares, boosting the clinical-stage company’s total haul to nearly $440 million. Braveheart’s lead drug could be competitive with a blockbuster Bristol Myers Squibb medicine for a type of cardiomyopathy. The post Braveheart Bio’s $382M IPO…

Read More
  • Medicine

MedCity FemFwd: Employer Strategies for Women’s Health

12 hours ago01 mins

In this episode, we’re joined by Cheryl Larson, president and CEO of the Midwest Business Group on Health, for our first in-person recording at MedCity News’ recent Bullseye event. The post MedCity FemFwd: Employer Strategies for Women’s Health appeared first on MedCity News.

Read More
  • Medicine

Two Differing POVs Emerge About the Hinge-Cylinder Deal

13 hours ago01 mins

Hinge Health’s acquisition of Cylinder expands it into GI care, but experts differ on whether employers will favor convenience or specialized solutions. The post Two Differing POVs Emerge About the Hinge-Cylinder Deal appeared first on MedCity News.

Read More
  • Medicine

Latigo Bio’s IPO Lands $346M for Pipeline of Non-Opioid Pain Drugs

17 hours ago01 mins

Latigo Biotherapeutics will apply the IPO proceeds toward a pipeline that includes a next-generation non-opioid pain drug ready for pivotal testing. BlossomHill Therapeutics also debuted on the Nasdaq, raising cash for cancer drugs designed to address mutations not covered by currently available therapies. The post Latigo Bio’s IPO Lands $346M for Pipeline of Non-Opioid Pain…

Read More
  • Medicine

Why Kidney Care’s Biggest Investment Wave Hasn’t Moved Hospital Costs

1 day ago01 mins

The problem may not be the investment. It may be the target of the intervention. The post Why Kidney Care’s Biggest Investment Wave Hasn’t Moved Hospital Costs appeared first on MedCity News.

Read More
  • 1
  • 2
  • 3
  • …
  • 764

Recent Posts

  • AI in Drug Development is Not a Data Problem — It’s An Evidence Problem
  • How to Keep Clinicians Satisfied, the Ascension Way
  • Compliance Alone Won’t Fix the Home Health Fraud Problem
  • Many States Cover Doula Care, but Access to a ‘Birthing Bestie’ Is Often Out of Reach
  • Same Knee Surgery, Twice the Price: Hospital Monopolies Push Up Healthcare Costs

Recent Comments

No comments to show.

Archives

  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • March 2024

Categories

  • Articles
  • Medicine
  • News
  • Other

You May Have Missed

  • Articles

CMS doesn’t consider QALYs – What’s a health economist to do?

12 months ago
  • Medicine

Rocket Pharmaceuticals Pulls FDA Filing for Rare Blood Disorder Gene Therapy

10 months ago
  • Other

Florida’s HIE Expansion Aims to End Fragmented Patient Information

1 month ago
  • Articles

‘MAHA Report’ Calls for Fighting Chronic Disease, but Trump and Kennedy Have Yanked Funding

1 year ago
  • Medicine

When Patients Understand, Hospitals Grow

3 months ago
  • Medicine

The $10 Million Problem in Every Biotech Lab: Why Answers Stay Hidden Without AI

8 months ago
  • Articles

How does socioeconomic status—and how it is measured—impact wait times?

2 years ago
  • Articles

V Bento, Sword Health

1 year ago
Newsmatic - News WordPress Theme 2026. Powered By BlazeThemes.